Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
45
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Dodrill Amy M. | President - Surgical Solutions | 55 | $0 | $350.8K | 2021-12-13 |
| Moore Gregory J. | Director | 6 | $0 | $0 | 2021-12-13 |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | 80 | $0 | $3.51M | 2021-12-13 |
| Norwood Felicia F | Director | 4 | $0 | $0 | 2021-12-13 |
| Bodem Barbara W. | SVP, Chief Financial Officer | 47 | $0 | $0 | 2021-12-13 |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | 106 | $0 | $3.82M | 2021-12-13 |
| Garrett Mary | Director | 12 | $25.0K | $0 | 2021-12-13 |
| Groetelaars John P | Chief Executive Officer | 48 | $0 | $0 | 2021-12-13 |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | 148 | $0 | $5.64M | 2021-12-13 |
| Wagner Richard M | Corporate Controller | 35 | $0 | $0 | 2021-12-13 |
| Kucheman William | Director | 20 | $0 | $0 | 2021-12-13 |
| SCHLICHTING NANCY M | Director | 10 | $0 | $0 | 2021-12-13 |
| Rasin Deborah | Sr. VP and CLO | 100 | $0 | $4.32M | 2021-12-13 |
| Enxing Seng Stacy | Director | 16 | $0 | $0 | 2021-12-13 |
| Ellis Gary Lee | Director | 10 | $0 | $0 | 2021-12-13 |
| DEMPSEY WILLIAM G | Executive Chair of the Board | 23 | $0 | $0 | 2021-12-13 |
| GIERTZ JAMES R | Director | 26 | $0 | $0 | 2021-12-13 |
| Meyers Kenneth F | Senior VP Chief HR Officer | 52 | $0 | $0 | 2020-11-11 |
| MALONE RONALD A | Director | 10 | $0 | $0 | 2020-02-26 |
| Canal Vega Francisco | SVP & Pres, Surgical Solutions | 10 | $0 | $0 | 2018-11-17 |
| ALONSO-MARUM CARLOS | SVP, President International | 22 | $0 | $0 | 2018-11-17 |
| SHADER ALTON | Sr VP & Pres Welch Allyn | 69 | $0 | $3.32M | 2018-11-17 |
| STROBEL STEVEN J | Senior Vice President and CFO | 20 | $0 | $0 | 2018-11-17 |
| Golden Charles E | Director | 43 | $0 | $194.2K | 2018-03-07 |
| GREISCH JOHN J | President and CEO | 78 | $0 | $32.32M | 2017-12-15 |
| Richardson Jason | VP, Controller & CAO | 39 | $0 | $284.2K | 2017-11-18 |
| CLASSON ROLF A | Director | 10 | $0 | $213.6K | 2017-03-14 |
| Solomon Carlyn D | Chief Operations Officer | 16 | $0 | $2.22M | 2016-11-18 |
| EHLERS DIRK H | SVP, Pres - Surgical Solutions | 3 | $0 | $0 | 2016-11-14 |
| MENASCE EDUARDO S | Director | 6 | $0 | $0 | 2016-09-19 |
| SMITH TAYLOR | SVP & Pres Surg. Resp. | 6 | $0 | $0 | 2015-11-16 |
| Keller Richard G | VP, Controller & CAO | 55 | $0 | $2.29M | 2015-11-16 |
| LICHTENSTEIN SUSAN R | Sr. VP and CLO | 18 | $0 | $0 | 2015-09-30 |
| ZWAAN MICHIEL DE | Senior VP Chief HR Officer | 8 | $0 | $0 | 2014-11-17 |
| Macek Michael S. | VP, Treasurer and Interim CFO | 16 | $0 | $122.1K | 2014-11-17 |
| MURPHY MICHAEL | Senior VP QA/RA | 10 | $0 | $0 | 2014-10-22 |
| LAWRENCE BRIAN | Chief Technology Officer | 7 | $0 | $0 | 2014-10-22 |
| Jeffers Scott R. | Sr. VP, Global Supply Chain | 10 | $0 | $0 | 2014-10-22 |
| Saracho Alejandro Infante | President, International | 10 | $0 | $0 | 2014-10-22 |
| SMITH JOANNE C DR | Director | 3 | $0 | $0 | 2014-03-10 |
| OLIVER MICHAEL O | Senior VP Chief HR Officer | 4 | $0 | $0 | 2013-11-18 |
| HILLENBRAND W AUGUST | Director | 14 | $0 | $105.4K | 2013-10-18 |
| GUINAN MARK | Sr. VP & CFO | 5 | $0 | $0 | 2012-12-14 |
| PRITCHARD EDWARD GREGORY | SVP & Pres Surg. Resp. | 3 | $200.6K | $0 | 2012-11-13 |
| Napier Katherine S | Director | 1 | $0 | $0 | 2012-03-07 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Moore Gregory J. | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,520 | — | $0 | 0 | SEC↗ |
| Moore Gregory J. | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,798 | — | $0 | 0 | SEC↗ |
| Moore Gregory J. | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,870 | — | $0 | 0 | SEC↗ |
| Bodem Barbara W. | SVP, Chief Financial Officer | D To issuer deriv | 2021-12-13 | 2021-12-15 | 3,026 | — | $0 | 0 | SEC↗ |
| Bodem Barbara W. | SVP, Chief Financial Officer | D To issuer deriv | 2021-12-13 | 2021-12-15 | 10,272 | $57.24 | $588.0K | 0 | SEC↗ |
| Bodem Barbara W. | SVP, Chief Financial Officer | D To issuer deriv | 2021-12-13 | 2021-12-15 | 15,491 | $52.89 | $819.3K | 0 | SEC↗ |
| Bodem Barbara W. | SVP, Chief Financial Officer | D To issuer deriv | 2021-12-13 | 2021-12-15 | 17,935 | $61.86 | $1.11M | 0 | SEC↗ |
| Bodem Barbara W. | SVP, Chief Financial Officer | D To issuer deriv | 2021-12-13 | 2021-12-15 | 7,452 | — | $0 | 0 | SEC↗ |
| Bodem Barbara W. | SVP, Chief Financial Officer | D To issuer deriv | 2021-12-13 | 2021-12-15 | 9,091 | — | $0 | 0 | SEC↗ |
| Bodem Barbara W. | SVP, Chief Financial Officer | D To issuer deriv | 2021-12-13 | 2021-12-15 | 13,951 | — | $0 | 0 | SEC↗ |
| Bodem Barbara W. | SVP, Chief Financial Officer | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,253 | — | $0 | 0 | SEC↗ |
| Garrett Mary | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 2,184 | — | $0 | 0 | SEC↗ |
| Garrett Mary | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,762 | — | $0 | 0 | SEC↗ |
| Garrett Mary | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,870 | — | $0 | 0 | SEC↗ |
| Garrett Mary | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,798 | — | $0 | 0 | SEC↗ |
| Garrett Mary | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 2,762 | — | $0 | 0 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | D To issuer deriv | 2021-12-13 | 2021-12-15 | 2,409 | $77.84 | $187.5K | 0 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | D To issuer deriv | 2021-12-13 | 2021-12-15 | 9,638 | $59.04 | $569.0K | 0 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | D To issuer deriv | 2021-12-13 | 2021-12-15 | 14,787 | $52.89 | $782.1K | 0 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | D To issuer deriv | 2021-12-13 | 2021-12-15 | 18,816 | $61.86 | $1.16M | 0 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | D To issuer deriv | 2021-12-13 | 2021-12-15 | 7,113 | — | $0 | 0 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | D To issuer deriv | 2021-12-13 | 2021-12-15 | 3,174 | — | $0 | 0 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,195 | — | $0 | 0 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | D To issuer deriv | 2021-12-13 | 2021-12-15 | 9,538 | — | $0 | 0 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | D To issuer deriv | 2021-12-13 | 2021-12-15 | 11,833 | — | $0 | 0 | SEC↗ |
| Norwood Felicia F | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,798 | — | $0 | 0 | SEC↗ |
| Norwood Felicia F | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,870 | — | $0 | 0 | SEC↗ |
| Dodrill Amy M. | President - Surgical Solutio | D To issuer deriv | 2021-12-13 | 2021-12-15 | 5,992 | $52.89 | $316.9K | 0 | SEC↗ |
| Dodrill Amy M. | President - Surgical Solutio | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,032 | $77.84 | $80.3K | 0 | SEC↗ |
| Dodrill Amy M. | President - Surgical Solutio | D To issuer deriv | 2021-12-13 | 2021-12-15 | 302 | $102.30 | $30.9K | 0 | SEC↗ |
| Dodrill Amy M. | President - Surgical Solutio | D To issuer deriv | 2021-12-13 | 2021-12-15 | 7,032 | — | $0 | 0 | SEC↗ |
| Dodrill Amy M. | President - Surgical Solutio | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,606 | — | $0 | 0 | SEC↗ |
| Dodrill Amy M. | President - Surgical Solutio | D To issuer deriv | 2021-12-13 | 2021-12-15 | 485 | — | $0 | 0 | SEC↗ |
| Dodrill Amy M. | President - Surgical Solutio | D To issuer deriv | 2021-12-13 | 2021-12-15 | 4,822 | — | $0 | 0 | SEC↗ |
| Dodrill Amy M. | President - Surgical Solutio | D To issuer deriv | 2021-12-13 | 2021-12-15 | 2,883 | — | $0 | 0 | SEC↗ |
| Dodrill Amy M. | President - Surgical Solutio | D To issuer deriv | 2021-12-13 | 2021-12-15 | 9,513 | $61.86 | $588.5K | 0 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | D To issuer deriv | 2021-12-13 | 2021-12-15 | 8,573 | $59.04 | $506.1K | 0 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | D To issuer deriv | 2021-12-13 | 2021-12-15 | 2,157 | — | $0 | 0 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | D To issuer deriv | 2021-12-13 | 2021-12-15 | 870 | — | $0 | 0 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | D To issuer deriv | 2021-12-13 | 2021-12-15 | 9,039 | $77.84 | $703.6K | 0 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | D To issuer deriv | 2021-12-13 | 2021-12-15 | 8,878 | — | $0 | 0 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | D To issuer deriv | 2021-12-13 | 2021-12-15 | 10,754 | $52.89 | $568.8K | 0 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | D To issuer deriv | 2021-12-13 | 2021-12-15 | 12,783 | $61.86 | $790.8K | 0 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | D To issuer deriv | 2021-12-13 | 2021-12-15 | 5,173 | — | $0 | 0 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | D To issuer deriv | 2021-12-13 | 2021-12-15 | 6,480 | — | $0 | 0 | SEC↗ |
| Kucheman William | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,762 | — | $0 | 0 | SEC↗ |
| Kucheman William | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,870 | — | $0 | 0 | SEC↗ |
| Kucheman William | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 2,762 | — | $0 | 0 | SEC↗ |
| Kucheman William | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 4,567 | — | $0 | 0 | SEC↗ |
| Kucheman William | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 4,262 | — | $0 | 0 | SEC↗ |
| Kucheman William | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 3,339 | — | $0 | 0 | SEC↗ |
| Kucheman William | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 3,385 | — | $0 | 0 | SEC↗ |
| Kucheman William | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 176 | — | $0 | 0 | SEC↗ |
| Kucheman William | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,798 | — | $0 | 0 | SEC↗ |
| Kucheman William | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 2,184 | — | $0 | 0 | SEC↗ |
| Wagner Richard M | Corporate Controller | D To issuer deriv | 2021-12-13 | 2021-12-15 | 706 | — | $0 | 0 | SEC↗ |
| Wagner Richard M | Corporate Controller | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,343 | — | $0 | 0 | SEC↗ |
| Wagner Richard M | Corporate Controller | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,634 | — | $0 | 0 | SEC↗ |
| Ellis Gary Lee | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,870 | — | $0 | 0 | SEC↗ |
| Ellis Gary Lee | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,024 | — | $0 | 0 | SEC↗ |
| Ellis Gary Lee | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 2,184 | — | $0 | 0 | SEC↗ |
| Ellis Gary Lee | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,762 | — | $0 | 0 | SEC↗ |
| Ellis Gary Lee | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,798 | — | $0 | 0 | SEC↗ |
| SCHLICHTING NANCY M | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,762 | — | $0 | 0 | SEC↗ |
| SCHLICHTING NANCY M | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 2,184 | — | $0 | 0 | SEC↗ |
| SCHLICHTING NANCY M | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 2,762 | — | $0 | 0 | SEC↗ |
| SCHLICHTING NANCY M | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,870 | — | $0 | 0 | SEC↗ |
| SCHLICHTING NANCY M | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,798 | — | $0 | 0 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | D To issuer deriv | 2021-12-13 | 2021-12-15 | 4,102 | $52.89 | $217.0K | 0 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | D To issuer deriv | 2021-12-13 | 2021-12-15 | 664 | — | $0 | 0 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | D To issuer deriv | 2021-12-13 | 2021-12-15 | 4,092 | — | $0 | 0 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | D To issuer deriv | 2021-12-13 | 2021-12-15 | 3,947 | — | $0 | 0 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | D To issuer deriv | 2021-12-13 | 2021-12-15 | 6,054 | $61.86 | $374.5K | 0 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,363 | — | $0 | 0 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | D To issuer deriv | 2021-12-13 | 2021-12-15 | 6,708 | — | $0 | 0 | SEC↗ |
| DEMPSEY WILLIAM G | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 4,262 | — | $0 | 0 | SEC↗ |
| DEMPSEY WILLIAM G | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 2,762 | — | $0 | 0 | SEC↗ |
| DEMPSEY WILLIAM G | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 176 | — | $0 | 0 | SEC↗ |
| DEMPSEY WILLIAM G | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 3,385 | — | $0 | 0 | SEC↗ |
| DEMPSEY WILLIAM G | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 2,669 | — | $0 | 0 | SEC↗ |
| DEMPSEY WILLIAM G | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 2,263 | — | $0 | 0 | SEC↗ |
| DEMPSEY WILLIAM G | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 2,176 | — | $0 | 0 | SEC↗ |
| DEMPSEY WILLIAM G | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 2,152 | — | $0 | 0 | SEC↗ |
| DEMPSEY WILLIAM G | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 3,339 | — | $0 | 0 | SEC↗ |
| GIERTZ JAMES R | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 3,498 | — | $0 | 0 | SEC↗ |
| GIERTZ JAMES R | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 3,992 | — | $0 | 0 | SEC↗ |
| GIERTZ JAMES R | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 4,567 | — | $0 | 0 | SEC↗ |
| GIERTZ JAMES R | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 4,262 | — | $0 | 0 | SEC↗ |
| GIERTZ JAMES R | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 3,339 | — | $0 | 0 | SEC↗ |
| GIERTZ JAMES R | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 3,385 | — | $0 | 0 | SEC↗ |
| GIERTZ JAMES R | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 176 | — | $0 | 0 | SEC↗ |
| GIERTZ JAMES R | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 2,762 | — | $0 | 0 | SEC↗ |
| GIERTZ JAMES R | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 2,184 | — | $0 | 0 | SEC↗ |
| GIERTZ JAMES R | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,762 | — | $0 | 0 | SEC↗ |
| GIERTZ JAMES R | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,870 | — | $0 | 0 | SEC↗ |
| GIERTZ JAMES R | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,798 | — | $0 | 0 | SEC↗ |
| GIERTZ JAMES R | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 2,865 | — | $0 | 0 | SEC↗ |
| GIERTZ JAMES R | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 959 | — | $0 | 0 | SEC↗ |
| Enxing Seng Stacy | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,870 | — | $0 | 0 | SEC↗ |
| Enxing Seng Stacy | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,762 | — | $0 | 0 | SEC↗ |
| Enxing Seng Stacy | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 2,184 | — | $0 | 0 | SEC↗ |
| Enxing Seng Stacy | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 2,762 | — | $0 | 0 | SEC↗ |
| Enxing Seng Stacy | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 176 | — | $0 | 0 | SEC↗ |
| Enxing Seng Stacy | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 3,385 | — | $0 | 0 | SEC↗ |
| Enxing Seng Stacy | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 3,339 | — | $0 | 0 | SEC↗ |
| Enxing Seng Stacy | Director | D To issuer deriv | 2021-12-13 | 2021-12-15 | 1,798 | — | $0 | 0 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | D To issuer deriv | 2021-12-13 | 2021-12-15 | 6,601 | $59.04 | $389.7K | 0 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | D To issuer deriv | 2021-12-13 | 2021-12-15 | 7,620 | $77.84 | $593.1K | 0 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | D To issuer deriv | 2021-12-13 | 2021-12-15 | 8,796 | — | $0 | 0 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | D To issuer deriv | 2021-12-13 | 2021-12-15 | 9,771 | $52.89 | $516.8K | 0 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | D To issuer deriv | 2021-12-13 | 2021-12-15 | 12,833 | $61.86 | $793.8K | 0 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | D To issuer deriv | 2021-12-13 | 2021-12-15 | 4,700 | — | $0 | 0 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | D To issuer deriv | 2021-12-13 | 2021-12-15 | 3,149 | $114.47 | $360.5K | 0 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | D To issuer deriv | 2021-12-13 | 2021-12-15 | 10,040 | $111.07 | $1.12M | 0 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | D To issuer deriv | 2021-12-13 | 2021-12-15 | 9,719 | $104.67 | $1.02M | 0 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | D To issuer deriv | 2021-12-13 | 2021-12-15 | 10,215 | $102.30 | $1.04M | 0 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | D To issuer deriv | 2021-12-13 | 2021-12-15 | 6,505 | — | $0 | 0 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | D To issuer deriv | 2021-12-13 | 2021-12-15 | 2,165 | — | $0 | 0 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | D To issuer deriv | 2021-12-13 | 2021-12-15 | 789 | — | $0 | 0 | SEC↗ |
| Groetelaars John P | Chief Executive Officer | D To issuer deriv | 2021-12-13 | 2021-12-15 | 4,128 | — | $0 | 0 | SEC↗ |
| Groetelaars John P | Chief Executive Officer | D To issuer deriv | 2021-12-13 | 2021-12-15 | 51,127 | $52.89 | $2.70M | 0 | SEC↗ |
| Groetelaars John P | Chief Executive Officer | D To issuer deriv | 2021-12-13 | 2021-12-15 | 59,783 | $61.86 | $3.70M | 0 | SEC↗ |
| Groetelaars John P | Chief Executive Officer | D To issuer deriv | 2021-12-13 | 2021-12-15 | 24,594 | — | $0 | 0 | SEC↗ |
| Groetelaars John P | Chief Executive Officer | D To issuer deriv | 2021-12-13 | 2021-12-15 | 30,304 | — | $0 | 0 | SEC↗ |
| Groetelaars John P | Chief Executive Officer | D To issuer deriv | 2021-12-13 | 2021-12-15 | 42,314 | $59.04 | $2.50M | 0 | SEC↗ |
| Groetelaars John P | Chief Executive Officer | D To issuer deriv | 2021-12-13 | 2021-12-15 | 10,083 | — | $0 | 0 | SEC↗ |
| Groetelaars John P | Chief Executive Officer | D To issuer deriv | 2021-12-13 | 2021-12-15 | 46,502 | — | $0 | 0 | SEC↗ |
| Groetelaars John P | Chief Executive Officer | D To issuer deriv | 2021-12-13 | 2021-12-15 | 39,962 | $66.92 | $2.67M | 0 | SEC↗ |
| Groetelaars John P | Chief Executive Officer | D To issuer deriv | 2021-12-13 | 2021-12-15 | 51,400 | $66.92 | $3.44M | 0 | SEC↗ |
| Bodem Barbara W. | SVP, Chief Financial Officer | D To issuer | 2021-12-13 | 2021-12-15 | 14,040 | — | $0 | 0 | SEC↗ |
| Garrett Mary | Director | D To issuer | 2021-12-13 | 2021-12-15 | 300 | — | $0 | 0 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | D To issuer | 2021-12-13 | 2021-12-15 | 13,566 | — | $0 | 0 | SEC↗ |
| Dodrill Amy M. | President - Surgical Solutio | D To issuer | 2021-12-13 | 2021-12-15 | 3,903 | — | $0 | 0 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | D To issuer | 2021-12-13 | 2021-12-15 | 26,527 | — | $0 | 0 | SEC↗ |
| Wagner Richard M | Corporate Controller | D To issuer | 2021-12-13 | 2021-12-15 | 5,693 | — | $0 | 0 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | D To issuer | 2021-12-13 | 2021-12-15 | 2,284 | — | $0 | 0 | SEC↗ |
| DEMPSEY WILLIAM G | Director | D To issuer | 2021-12-13 | 2021-12-15 | 5,376 | — | $0 | 0 | SEC↗ |
| GIERTZ JAMES R | Director | D To issuer | 2021-12-13 | 2021-12-15 | 2,000 | — | $0 | 0 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | D To issuer | 2021-12-13 | 2021-12-15 | 16,539 | — | $0 | 0 | SEC↗ |
| Groetelaars John P | Chief Executive Officer | D To issuer | 2021-12-13 | 2021-12-15 | 34,870 | — | $0 | 0 | SEC↗ |
| Bodem Barbara W. | SVP, Chief Financial Officer | M Exercise deriv | 2021-12-06 | 2021-12-08 | 2,640 | — | $0 | 0 | SEC↗ |
| Bodem Barbara W. | SVP, Chief Financial Officer | M Exercise deriv | 2021-12-06 | 2021-12-08 | 992 | — | $0 | 0 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | M Exercise deriv | 2021-12-06 | 2021-12-08 | 361 | — | $0 | 0 | SEC↗ |
| Bodem Barbara W. | SVP, Chief Financial Officer | G Gift | 2021-12-06 | 2021-12-08 | 2,000 | — | $0 | 13,321 | SEC↗ |
| Bodem Barbara W. | SVP, Chief Financial Officer | M Exercise | 2021-12-06 | 2021-12-08 | 2,640 | — | $0 | 16,513 | SEC↗ |
| Bodem Barbara W. | SVP, Chief Financial Officer | F Tax w/h | 2021-12-06 | 2021-12-08 | 448 | $155.73 | $69.8K | 13,873 | SEC↗ |
| Bodem Barbara W. | SVP, Chief Financial Officer | M Exercise | 2021-12-06 | 2021-12-08 | 992 | — | $0 | 14,321 | SEC↗ |
| Bodem Barbara W. | SVP, Chief Financial Officer | F Tax w/h | 2021-12-06 | 2021-12-08 | 1,192 | $155.73 | $185.6K | 15,321 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | M Exercise | 2021-12-06 | 2021-12-08 | 361 | — | $0 | 16,731 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | F Tax w/h | 2021-12-06 | 2021-12-08 | 192 | $155.73 | $29.9K | 16,539 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | G Gift | 2021-11-24 | 2021-12-08 | 5,300 | — | $0 | 16,370 | SEC↗ |
| Dodrill Amy M. | President - Surgical Solutio | M Exercise deriv | 2021-11-12 | 2021-11-16 | 825 | — | $0 | 1,586 | SEC↗ |
| Wagner Richard M | Corporate Controller | M Exercise deriv | 2021-11-12 | 2021-11-16 | 840 | — | $0 | 1,614 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | M Exercise deriv | 2021-11-12 | 2021-11-16 | 1,109 | — | $0 | 2,131 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | M Exercise deriv | 2021-11-12 | 2021-11-16 | 1,115 | — | $0 | 2,138 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | M Exercise deriv | 2021-11-12 | 2021-11-16 | 1,634 | — | $0 | 3,135 | SEC↗ |
| Bodem Barbara W. | SVP, Chief Financial Officer | M Exercise deriv | 2021-11-12 | 2021-11-16 | 1,557 | — | $0 | 2,989 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | M Exercise deriv | 2021-11-12 | 2021-11-16 | 700 | — | $0 | 1,346 | SEC↗ |
| Groetelaars John P | Chief Executive Officer | M Exercise deriv | 2021-11-12 | 2021-11-16 | 5,193 | — | $0 | 9,959 | SEC↗ |
| Dodrill Amy M. | President - Surgical Solutio | F Tax w/h | 2021-11-12 | 2021-11-16 | 242 | $155.11 | $37.5K | 3,793 | SEC↗ |
| Dodrill Amy M. | President - Surgical Solutio | M Exercise | 2021-11-12 | 2021-11-16 | 825 | — | $0 | 4,035 | SEC↗ |
| Wagner Richard M | Corporate Controller | F Tax w/h | 2021-11-12 | 2021-11-16 | 243 | $155.11 | $37.7K | 5,210 | SEC↗ |
| Wagner Richard M | Corporate Controller | M Exercise | 2021-11-12 | 2021-11-16 | 840 | — | $0 | 5,453 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | F Tax w/h | 2021-11-12 | 2021-11-16 | 492 | $155.11 | $76.3K | 26,527 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | M Exercise | 2021-11-12 | 2021-11-16 | 1,109 | — | $0 | 27,019 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | F Tax w/h | 2021-11-12 | 2021-11-16 | 593 | $155.11 | $92.0K | 21,670 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | M Exercise | 2021-11-12 | 2021-11-16 | 1,115 | — | $0 | 22,263 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | F Tax w/h | 2021-11-12 | 2021-11-16 | 724 | $155.11 | $112.3K | 13,566 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | M Exercise | 2021-11-12 | 2021-11-16 | 1,634 | — | $0 | 14,290 | SEC↗ |
| Bodem Barbara W. | SVP, Chief Financial Officer | M Exercise | 2021-11-12 | 2021-11-16 | 1,557 | — | $0 | 14,028 | SEC↗ |
| Bodem Barbara W. | SVP, Chief Financial Officer | F Tax w/h | 2021-11-12 | 2021-11-16 | 699 | $155.11 | $108.4K | 13,329 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | M Exercise | 2021-11-12 | 2021-11-16 | 700 | — | $0 | 2,537 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | F Tax w/h | 2021-11-12 | 2021-11-16 | 253 | $155.11 | $39.2K | 2,284 | SEC↗ |
| Groetelaars John P | Chief Executive Officer | F Tax w/h | 2021-11-12 | 2021-11-16 | 2,044 | $155.11 | $317.0K | 38,019 | SEC↗ |
| Groetelaars John P | Chief Executive Officer | M Exercise | 2021-11-12 | 2021-11-16 | 5,193 | — | $0 | 40,063 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | M Exercise deriv | 2021-11-11 | 2021-11-12 | 2,018 | — | $0 | 6,054 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | M Exercise | 2021-11-11 | 2021-11-12 | 2,018 | $94.14 | $190.0K | 3,855 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | S Sale | 2021-11-11 | 2021-11-12 | 2,018 | $155.14 | $313.1K | 1,837 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | A Award deriv | 2021-11-10 | 2021-11-12 | 6,708 | — | $0 | 6,708 | SEC↗ |
| Dodrill Amy M. | President - Surgical Solutio | A Award deriv | 2021-11-10 | 2021-11-12 | 7,032 | — | $0 | 7,032 | SEC↗ |
| Bodem Barbara W. | SVP, Chief Financial Officer | A Award deriv | 2021-11-10 | 2021-11-12 | 13,951 | — | $0 | 13,951 | SEC↗ |
| Groetelaars John P | Chief Executive Officer | A Award deriv | 2021-11-10 | 2021-11-12 | 46,502 | — | $0 | 46,502 | SEC↗ |
| Wagner Richard M | Corporate Controller | A Award deriv | 2021-11-10 | 2021-11-12 | 1,343 | — | $0 | 1,343 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | A Award deriv | 2021-11-10 | 2021-11-12 | 8,796 | — | $0 | 8,796 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | A Award deriv | 2021-11-10 | 2021-11-12 | 11,833 | — | $0 | 11,833 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | A Award deriv | 2021-11-10 | 2021-11-12 | 8,878 | — | $0 | 8,878 | SEC↗ |
| Groetelaars John P | Chief Executive Officer | G Gift | 2021-11-10 | 2021-11-17 | 16,895 | — | $0 | 34,870 | SEC↗ |
| Bodem Barbara W. | SVP, Chief Financial Officer | M Exercise deriv | 2021-11-08 | 2021-11-10 | 1,249 | — | $0 | 1,232 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | M Exercise deriv | 2021-11-08 | 2021-11-10 | 938 | — | $0 | 0 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | M Exercise deriv | 2021-11-08 | 2021-11-10 | 1,193 | — | $0 | 1,176 | SEC↗ |
| Dodrill Amy M. | President - Surgical Solutio | M Exercise deriv | 2021-11-08 | 2021-11-10 | 483 | — | $0 | 478 | SEC↗ |
| Dodrill Amy M. | President - Surgical Solutio | M Exercise deriv | 2021-11-08 | 2021-11-10 | 469 | — | $0 | 0 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | M Exercise deriv | 2021-11-08 | 2021-11-10 | 789 | — | $0 | 776 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | M Exercise deriv | 2021-11-08 | 2021-11-10 | 644 | — | $0 | 0 | SEC↗ |
| Groetelaars John P | Chief Executive Officer | M Exercise deriv | 2021-11-08 | 2021-11-10 | 4,114 | — | $0 | 0 | SEC↗ |
| Groetelaars John P | Chief Executive Officer | M Exercise deriv | 2021-11-08 | 2021-11-10 | 4,127 | — | $0 | 4,061 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | M Exercise deriv | 2021-11-08 | 2021-11-10 | 662 | — | $0 | 653 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | M Exercise deriv | 2021-11-08 | 2021-11-10 | 1,937 | — | $0 | 0 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | M Exercise deriv | 2021-11-08 | 2021-11-10 | 2,051 | — | $0 | 4,102 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | M Exercise deriv | 2021-11-08 | 2021-11-10 | 872 | — | $0 | 0 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | M Exercise deriv | 2021-11-08 | 2021-11-10 | 835 | — | $0 | 0 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | M Exercise deriv | 2021-11-08 | 2021-11-10 | 868 | — | $0 | 856 | SEC↗ |
| Wagner Richard M | Corporate Controller | M Exercise deriv | 2021-11-08 | 2021-11-10 | 704 | — | $0 | 694 | SEC↗ |
| Wagner Richard M | Corporate Controller | M Exercise deriv | 2021-11-08 | 2021-11-10 | 740 | — | $0 | 0 | SEC↗ |
| Bodem Barbara W. | SVP, Chief Financial Officer | F Tax w/h | 2021-11-08 | 2021-11-10 | 561 | $155.09 | $87.0K | 12,471 | SEC↗ |
| Bodem Barbara W. | SVP, Chief Financial Officer | M Exercise | 2021-11-08 | 2021-11-10 | 1,249 | — | $0 | 13,032 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | F Tax w/h | 2021-11-08 | 2021-11-10 | 529 | $155.09 | $82.0K | 12,656 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | M Exercise | 2021-11-08 | 2021-11-10 | 938 | — | $0 | 12,408 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | F Tax w/h | 2021-11-08 | 2021-11-10 | 416 | $155.09 | $64.5K | 11,992 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | M Exercise | 2021-11-08 | 2021-11-10 | 1,193 | — | $0 | 13,185 | SEC↗ |
| Dodrill Amy M. | President - Surgical Solutio | F Tax w/h | 2021-11-08 | 2021-11-10 | 141 | $155.09 | $21.9K | 2,895 | SEC↗ |
| Dodrill Amy M. | President - Surgical Solutio | M Exercise | 2021-11-08 | 2021-11-10 | 469 | — | $0 | 3,036 | SEC↗ |
| Dodrill Amy M. | President - Surgical Solutio | M Exercise | 2021-11-08 | 2021-11-10 | 483 | — | $0 | 3,378 | SEC↗ |
| Dodrill Amy M. | President - Surgical Solutio | F Tax w/h | 2021-11-08 | 2021-11-10 | 168 | $155.09 | $26.1K | 3,210 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | F Tax w/h | 2021-11-08 | 2021-11-10 | 330 | $155.09 | $51.2K | 21,148 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | M Exercise | 2021-11-08 | 2021-11-10 | 789 | — | $0 | 21,478 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | F Tax w/h | 2021-11-08 | 2021-11-10 | 343 | $155.09 | $53.2K | 20,689 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | M Exercise | 2021-11-08 | 2021-11-10 | 644 | — | $0 | 21,032 | SEC↗ |
| Groetelaars John P | Chief Executive Officer | F Tax w/h | 2021-11-08 | 2021-11-10 | 1,712 | $155.09 | $265.5K | 49,360 | SEC↗ |
| Groetelaars John P | Chief Executive Officer | M Exercise | 2021-11-08 | 2021-11-10 | 4,114 | — | $0 | 51,072 | SEC↗ |
| Groetelaars John P | Chief Executive Officer | M Exercise | 2021-11-08 | 2021-11-10 | 4,127 | — | $0 | 53,487 | SEC↗ |
| Groetelaars John P | Chief Executive Officer | F Tax w/h | 2021-11-08 | 2021-11-10 | 1,722 | $155.09 | $267.1K | 51,765 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | S Sale | 2021-11-08 | 2021-11-10 | 872 | $155.08 | $135.2K | 0 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | F Tax w/h | 2021-11-08 | 2021-11-10 | 568 | $155.09 | $88.1K | 1,369 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | M Exercise | 2021-11-08 | 2021-11-10 | 662 | — | $0 | 2,031 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | M Exercise | 2021-11-08 | 2021-11-10 | 1,937 | — | $0 | 1,937 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | F Tax w/h | 2021-11-08 | 2021-11-10 | 194 | $155.09 | $30.1K | 1,837 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | S Sale | 2021-11-08 | 2021-11-10 | 2,051 | $155.08 | $318.1K | 0 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | M Exercise | 2021-11-08 | 2021-11-10 | 2,051 | $103.11 | $211.5K | 2,051 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | M Exercise | 2021-11-08 | 2021-11-10 | 872 | $78.16 | $68.2K | 872 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | F Tax w/h | 2021-11-08 | 2021-11-10 | 385 | $155.09 | $59.7K | 25,910 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | M Exercise | 2021-11-08 | 2021-11-10 | 835 | — | $0 | 25,797 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | F Tax w/h | 2021-11-08 | 2021-11-10 | 370 | $155.09 | $57.4K | 25,427 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | M Exercise | 2021-11-08 | 2021-11-10 | 868 | — | $0 | 26,295 | SEC↗ |
| Wagner Richard M | Corporate Controller | F Tax w/h | 2021-11-08 | 2021-11-10 | 215 | $155.09 | $33.3K | 4,113 | SEC↗ |
| Wagner Richard M | Corporate Controller | M Exercise | 2021-11-08 | 2021-11-10 | 704 | — | $0 | 4,817 | SEC↗ |
| Wagner Richard M | Corporate Controller | M Exercise | 2021-11-08 | 2021-11-10 | 740 | — | $0 | 4,328 | SEC↗ |
| Wagner Richard M | Corporate Controller | F Tax w/h | 2021-11-08 | 2021-11-10 | 204 | $155.09 | $31.6K | 4,613 | SEC↗ |
| Bodem Barbara W. | SVP, Chief Financial Officer | F Tax w/h | 2021-11-01 | 2021-11-03 | 3,102 | $155.17 | $481.3K | 11,783 | SEC↗ |
| Bodem Barbara W. | SVP, Chief Financial Officer | A Award | 2021-11-01 | 2021-11-03 | 9,017 | — | $0 | 14,885 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | F Tax w/h | 2021-11-01 | 2021-11-03 | 2,230 | $155.17 | $346.0K | 20,388 | SEC↗ |
| FRANK ANDREAS G | SVP, Pres. Front Line Care | A Award | 2021-11-01 | 2021-11-03 | 5,848 | — | $0 | 22,618 | SEC↗ |
| Groetelaars John P | Chief Executive Officer | F Tax w/h | 2021-11-01 | 2021-11-03 | 15,593 | $155.17 | $2.42M | 46,958 | SEC↗ |
| Groetelaars John P | Chief Executive Officer | A Award | 2021-11-01 | 2021-11-03 | 37,476 | — | $0 | 62,551 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | A Award | 2021-11-01 | 2021-11-03 | 8,537 | — | $0 | 14,758 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | F Tax w/h | 2021-11-01 | 2021-11-03 | 3,288 | $155.17 | $510.2K | 11,470 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | A Award | 2021-11-01 | 2021-11-03 | 7,593 | — | $0 | 27,537 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | F Tax w/h | 2021-11-01 | 2021-11-03 | 2,575 | $155.17 | $399.6K | 24,962 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | M Exercise deriv | 2021-07-28 | 2021-07-30 | 1,307 | $78.16 | $102.2K | 872 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | M Exercise deriv | 2021-07-28 | 2021-07-30 | 2,051 | $103.11 | $211.5K | 6,153 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | S Sale | 2021-07-28 | 2021-07-30 | 1,307 | $125.00 | $163.4K | 0 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | S Sale | 2021-07-28 | 2021-07-30 | 3,000 | $125.00 | $375.0K | 2,698 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | S Sale | 2021-07-28 | 2021-07-30 | 2,051 | $130.00 | $266.6K | 0 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | M Exercise | 2021-07-28 | 2021-07-30 | 2,051 | $103.11 | $211.5K | 2,051 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | M Exercise | 2021-07-28 | 2021-07-30 | 1,307 | $78.16 | $102.2K | 1,307 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | S Sale | 2021-07-28 | 2021-07-30 | 2,698 | $130.00 | $350.7K | 0 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | M Exercise deriv | 2021-07-23 | 2021-07-27 | 1,307 | $78.16 | $102.2K | 2,179 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | M Exercise deriv | 2021-07-23 | 2021-07-27 | 1,042 | $53.70 | $56.0K | 0 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | M Exercise | 2021-07-23 | 2021-07-27 | 1,307 | $78.16 | $102.2K | 7,005 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | S Sale | 2021-07-23 | 2021-07-27 | 1,042 | $120.00 | $125.0K | 5,698 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | M Exercise | 2021-07-23 | 2021-07-27 | 1,042 | $53.70 | $56.0K | 6,740 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | S Sale | 2021-07-23 | 2021-07-27 | 6,000 | $120.00 | $720.0K | 5,698 | SEC↗ |
| Ladone Mary Kay | SVP, Corp. Dev., Strat. & IR | S Sale | 2021-07-23 | 2021-07-27 | 1,307 | $120.00 | $156.8K | 5,698 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | S Sale | 2021-06-10 | 2021-06-11 | 1,833 | $113.49 | $208.0K | 21,211 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | S Sale | 2021-06-10 | 2021-06-11 | 1,267 | $114.12 | $144.6K | 19,944 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | S Sale | 2021-06-10 | 2021-06-11 | 1,900 | $112.57 | $213.9K | 23,044 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | M Exercise deriv | 2021-06-07 | 2021-06-09 | 3,223 | $53.70 | $173.1K | 0 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | S Sale | 2021-06-07 | 2021-06-09 | 1,546 | $110.52 | $170.9K | 28,398 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | S Sale | 2021-06-07 | 2021-06-09 | 1,512 | $110.51 | $167.1K | 30,432 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | S Sale | 2021-06-07 | 2021-06-09 | 488 | $111.21 | $54.3K | 29,944 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | S Sale | 2021-06-07 | 2021-06-09 | 659 | $111.26 | $73.3K | 24,944 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | S Sale | 2021-06-07 | 2021-06-09 | 2,564 | $110.52 | $283.4K | 25,603 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | M Exercise | 2021-06-07 | 2021-06-09 | 3,223 | $53.70 | $173.1K | 28,167 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | S Sale | 2021-06-07 | 2021-06-09 | 601 | $111.24 | $66.9K | 24,944 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | S Sale | 2021-06-07 | 2021-06-09 | 2,399 | $110.52 | $265.1K | 25,545 | SEC↗ |
| Rasin Deborah | SVP, Chief Legal Officer | S Sale | 2021-06-07 | 2021-06-09 | 454 | $111.25 | $50.5K | 27,944 | SEC↗ |
| Groetelaars John P | Chief Executive Officer | M Exercise deriv | 2021-05-17 | 2021-05-18 | 11,805 | — | $0 | 0 | SEC↗ |
| Groetelaars John P | Chief Executive Officer | M Exercise | 2021-05-17 | 2021-05-18 | 11,805 | $110.90 | $1.31M | 28,700 | SEC↗ |
| Groetelaars John P | Chief Executive Officer | F Tax w/h | 2021-05-17 | 2021-05-18 | 3,625 | $110.90 | $402.0K | 25,075 | SEC↗ |
| Wagner Richard M | Corporate Controller | M Exercise deriv | 2021-04-26 | 2021-04-28 | 973 | — | $0 | 0 | SEC↗ |
| Wagner Richard M | Corporate Controller | M Exercise | 2021-04-26 | 2021-04-28 | 973 | $115.65 | $112.5K | 3,888 | SEC↗ |
| Wagner Richard M | Corporate Controller | F Tax w/h | 2021-04-26 | 2021-04-28 | 300 | $115.65 | $34.7K | 3,588 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | M Exercise deriv | 2021-04-08 | 2021-04-12 | 699 | — | $0 | 0 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | M Exercise deriv | 2021-04-08 | 2021-04-12 | 3,651 | — | $0 | 0 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | M Exercise deriv | 2021-04-08 | 2021-04-12 | 7,225 | — | $0 | 2,409 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | S Sale | 2021-04-08 | 2021-04-12 | 699 | $111.08 | $77.6K | 6,221 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | M Exercise | 2021-04-08 | 2021-04-12 | 3,651 | $53.70 | $196.1K | 9,872 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | M Exercise | 2021-04-08 | 2021-04-12 | 7,225 | $78.16 | $564.7K | 13,446 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | S Sale | 2021-04-08 | 2021-04-12 | 7,225 | $111.04 | $802.3K | 6,221 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | M Exercise | 2021-04-08 | 2021-04-12 | 699 | $51.33 | $35.9K | 6,920 | SEC↗ |
| Johnson Paul Sherwood | SVP & Pres. - PSS Acute Care | S Sale | 2021-04-08 | 2021-04-12 | 3,651 | $111.05 | $405.4K | 6,221 | SEC↗ |
| DEMPSEY WILLIAM G | Director | A Award deriv | 2021-03-11 | 2021-03-12 | 2,163 | — | $0 | 2,163 | SEC↗ |
| Ellis Gary Lee | Director | A Award deriv | 2021-03-11 | 2021-03-12 | 1,787 | — | $0 | 1,787 | SEC↗ |
| Kucheman William | Director | A Award deriv | 2021-03-11 | 2021-03-12 | 1,787 | — | $0 | 1,787 | SEC↗ |
| Enxing Seng Stacy | Director | A Award deriv | 2021-03-11 | 2021-03-12 | 1,787 | — | $0 | 1,787 | SEC↗ |
| Norwood Felicia F | Director | A Award deriv | 2021-03-11 | 2021-03-12 | 1,787 | — | $0 | 1,787 | SEC↗ |
| Moore Gregory J. | Director | A Award deriv | 2021-03-11 | 2021-03-12 | 1,787 | — | $0 | 1,787 | SEC↗ |
| SCHLICHTING NANCY M | Director | A Award deriv | 2021-03-11 | 2021-03-12 | 1,787 | — | $0 | 1,787 | SEC↗ |
| GIERTZ JAMES R | Director | A Award deriv | 2021-03-11 | 2021-03-12 | 1,787 | — | $0 | 1,787 | SEC↗ |
| Garrett Mary | Director | A Award deriv | 2021-03-11 | 2021-03-15 | 1,787 | — | $0 | 1,787 | SEC↗ |